Upadacitinib in patients with moderate/severe rheumatoid arthritis: 12-month data from Germany, Austria, and Switzerland in the observational UPHOLD study

Introduction: Upadacitinib (UPA), an oral, reversible JAK inhibitor, has shown efficacy and an acceptable safety profile in rheumatoid arthritis (RA) [ref:1], [ref:2], [ref:3], [ref:4], [ref:5], [ref:6]. However, real-world data on UPA in clinical [for full text, please go to the a.m. URL]

Institutions

Publication Details

Journal
German Medical Science (German Research Foundation)
Published
2024-09-18
DOI
https://doi.org/10.3205/24dgrh160
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Upadacitinib in patients with moderate/severe rheumatoid arthritis: 12-month data from Germany, Austria, and Switzerland in the observational UPHOLD study

German Medical Science (German Research Foundation)
Rheumatoid Arthritis Research and Therapies
article

Upadacitinib in patients with moderate/severe rheumatoid arthritis: 12-month data from Germany, Austria, and Switzerland in the observational UPHOLD study

article en

Abstract

Introduction: Upadacitinib (UPA), an oral, reversible JAK inhibitor, has shown efficacy and an acceptable safety profile in rheumatoid arthritis (RA) [ref:1], [ref:2], [ref:3], [ref:4], [ref:5], [ref:6]. However, real-world data on UPA in clinical [for full text, please go to the a.m. URL]

German Medical Science (German Research Foundation)
University of St.Gallen (CH), Temple College (US), AbbVie (United States) (US), Helios Klinikum Emil von Behring (DE), University of Applied Sciences Erfurt (DE), Experimental Factory Magdeburg (DE), AbbVie (Germany) (DE), Center for HIV and Hepatogastroenterology (DE), ABB (Switzerland) (CH)
Good health and well-being
Openalex Percentile: Top 49%
Rheumatoid Arthritis Research and Therapies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Upadacitinib in patients with moderate/severe rheumatoid arthritis: 12-month data from Germany, Austria, and Switzerland in the observational UPHOLD study · German Medical Science (German Research Foundation) (2024) | TGRS Research Map | TGRS